Département de cardiologie, CHU de Nancy, 54511 Vandœuvre-lès-Nancy, France.
Département de cardiologie, CHU de Nancy, 54511 Vandœuvre-lès-Nancy, France; Université de Lorraine, 54000 Nancy, France.
Arch Cardiovasc Dis. 2017 Oct;110(10):508-516. doi: 10.1016/j.acvd.2017.03.004. Epub 2017 Jun 21.
As the number of transcatheter aortic valve implantation (TAVI) procedures is constantly increasing, it is important to consider common complications, such as pacemaker (PM) implantation, and their specific risk factors.
Echocardiographic, computed tomography and electrocardiographic data were analysed to determine the predicting factors, if any, associated with PM implantation.
This retrospective study included patients referred to Nancy University Hospital for a TAVI procedure from January 2013 to December 2015. Both Medtronic CoreValve and Edwards SAPIEN valves were implanted. Patients with preprocedurally implanted PMs and/or referred from another institution were excluded.
Of 208 TAVI patients, 23 had a pre-existing PM and were excluded. A new PM was required in 38 patients (20.5%). Pre-existing right bundle branch block (RBBB), the use of the Medtronic CoreValve and large prostheses were identified as predictors of PM implantation (P=0.0361, P=0.0004 and P=0.0019, respectively). Using logistic regression, predictors of PM implantation included first-degree atrioventricular block (odds ratio 3.7, 95% confidence interval 1.5-9.1; P=0.0054) and large aortic annulus diameter in echocardiography (odds ratio 1.2, 95% confidence interval 1-1.4; P=0.0447), with a threshold of 24.1mm. For the combination of preTAVI PR duration >220ms and QRS duration >120ms, the positive predictive value for PM implantation reached 80%.
Use of the Medtronic CoreValve, RBBB and first-degree atrioventricular block are major risk factors for post-TAVI PM implantation. In addition, large aortic annulus and large valvular prosthesis are independent risk factors for PM implantation. The combination of preTAVI prolonged PR interval and increased QRS duration could be used as a marker for periprocedural PM implantation.
随着经导管主动脉瓣植入术(TAVI)数量的不断增加,考虑常见并发症(如起搏器(PM)植入)及其特定危险因素非常重要。
分析超声心动图、计算机断层扫描和心电图数据,以确定与 PM 植入相关的任何预测因素。
这项回顾性研究纳入了 2013 年 1 月至 2015 年 12 月在南锡大学医院接受 TAVI 手术的患者。植入了美敦力 CoreValve 和爱德华兹 SAPIEN 瓣膜。排除了术前植入 PM 且/或转院的患者。
在 208 例 TAVI 患者中,有 23 例患者术前已植入 PM,故将其排除。38 例(20.5%)患者需要植入新的 PM。术前存在右束支传导阻滞(RBBB)、使用美敦力 CoreValve 和大瓣膜是 PM 植入的预测因素(P=0.0361、P=0.0004 和 P=0.0019)。使用逻辑回归,PM 植入的预测因素包括一度房室传导阻滞(优势比 3.7,95%置信区间 1.5-9.1;P=0.0054)和超声心动图中较大的主动脉瓣环直径(优势比 1.2,95%置信区间 1-1.4;P=0.0447),阈值为 24.1mm。对于术前 PR 间期>220ms 和 QRS 间期>120ms 的组合,PM 植入的阳性预测值达到 80%。
使用美敦力 CoreValve、RBBB 和一度房室传导阻滞是 TAVI 术后 PM 植入的主要危险因素。此外,较大的主动脉瓣环和较大的瓣膜假体是 PM 植入的独立危险因素。术前 PR 间期延长和 QRS 间期增加可作为术中 PM 植入的标志物。